Mike Mulqueen, VP of Business Development will be presenting @eTheRNA_immuno at the upcoming Immuno-Oncology Innovation Forum.

e-Meet eTheRNA immunotherapies at #Sachs_IOIF

More info @ https://t.co/tMBHnCypoC pic.twitter.com/8WMFDzNzFF

— Sachs Associates (@SachsAssociates) May 4, 2021